WallStreetZenWallStreetZen

NASDAQ: ALLR
Allarity Therapeutics Inc Stock

$0.24+0.01 (+4.35%)
Updated Jan 27, 2023
ALLR Price
$0.24
Fair Value Price
N/A
Market Cap
$2.49M
52 Week Low
$0.20
52 Week High
$9.67
P/E
-0.05x
P/B
1.72x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$30.04M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
10.11
Operating Cash Flow
-$19M
Beta
1.32
Next Earnings
Mar 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ALLR Overview

Allarity Therapeutics is a biopharma company developing oncology products and drugs for the personalized treatment of cancer. The company uses Drug Response Predictor (DRP®) technology to advance therapeutic candidates by targeting and evaluating patient sub-populations having gene signatures. Its pipeline products include Dovitinib, Stenoparib, Ixempra, and other formulations. Allarity was incorporated in 2004 and is headquartered in Cambridge, MA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ALLR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ALLR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ALLR is good value based on its book value relative to its share price (1.72x), compared to the US Biotechnology industry average (5.18x)
P/B vs Industry Valuation
ALLR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ALLR due diligence checks available for Premium users.

Be the first to know about important ALLR news, forecast changes, insider trades & much more!

ALLR News

Valuation

ALLR fair value

Fair Value of ALLR stock based on Discounted Cash Flow (DCF)
Price
$0.24
Fair Value
$0.63
Undervalued by
62.01%
ALLR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ALLR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.05x
Industry
12.89x
Market
23.59x

ALLR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.72x
Industry
5.18x
ALLR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ALLR's financial health

Profit margin

Revenue
$0.0
Net Income
-$5.0M
Profit Margin
0%
ALLR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$18.1M
Liabilities
$14.6M
Debt to equity
10.11
ALLR's short-term liabilities ($12.96M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALLR's short-term assets ($6.06M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALLR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.4M
Investing
$0.0
Financing
$0.0
ALLR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ALLR vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ALLR$2.49M+4.29%-0.05x1.72x
MTP$2.62M+1.37%-0.78x0.31x
CYTO$2.36M-12.89%-0.11x0.29x
CFRX$2.71M-25.00%-0.05x-0.87x
SPRC$2.77M-3.03%1.04x1.12x

Allarity Therapeutics Stock FAQ

What is Allarity Therapeutics's quote symbol?

NASDAQ: ALLR) Allarity Therapeutics trades on the NASDAQ under the ticker symbol ALLR. Allarity Therapeutics stock quotes can also be displayed as NASDAQ: ALLR.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.

What is the 52 week high and low for Allarity Therapeutics (NASDAQ: ALLR)?

(NASDAQ: ALLR) Allarity Therapeutics's 52-week high was $9.67, and its 52-week low was $0.20. It is currently -97.49% from its 52-week high and 21.5% from its 52-week low.

How much is Allarity Therapeutics stock worth today?

(NASDAQ: ALLR) Allarity Therapeutics currently has 10,260,157 outstanding shares. With Allarity Therapeutics stock trading at $0.24 per share, the total value of Allarity Therapeutics stock (market capitalization) is $2.49M.

Allarity Therapeutics stock was originally listed at a price of $12.63 in Dec 22, 2021. If you had invested in Allarity Therapeutics stock at $12.63, your return over the last 1 years would have been -98.08%, for an annualized return of -98.08% (not including any dividends or dividend reinvestments).

How much is Allarity Therapeutics's stock price per share?

(NASDAQ: ALLR) Allarity Therapeutics stock price per share is $0.24 today (as of Jan 27, 2023).

What is Allarity Therapeutics's Market Cap?

(NASDAQ: ALLR) Allarity Therapeutics's market cap is $2.49M, as of Jan 29, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Allarity Therapeutics's market cap is calculated by multiplying ALLR's current stock price of $0.24 by ALLR's total outstanding shares of 10,260,157.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.